With more than 15 years of combined experience in Reproductive Endocrinology and Infertility,Dr. Eric Knochenhauer, Dr. Michael Traub and their knowledgeable team at Island Reproductive Services (IRS) have focused their skills and compassion on successfully helping metro New York and New Jersey patients become parents.
Centered on the mission of providing supportive, patient-oriented fertility care in a relaxed, non-threatening environment, Island Reproductive Services approach and treat each patient as an individual. Their excellent success rates are a product of comprehensive, skilled diagnosis and careful treatment. Their focused approach ensures that each patient’s treatment plan is based on what is the most direct and effective path to parenthood for that patient’s unique situation.
Founded by Dr. Eric Knochenhauer, Island Reproductive Services is a free-standing, full-service fertility center and laboratory that has full accreditation by both the Joint Commission and the AAAASC (American Association for Accreditation of Ambulatory Surgery Centers). Dr. Knochenhauer also serves as the Director of Reproductive Endocrinology and Infertility at Staten Island University Hospital, in SI, NY. The IRS team is comprised of skilled, compassionate nurses and clinical support staff, as well as financial counseling and administrative personnel who are dedicated to helping patients achieve their dream of building a family. Their skilled PhD / High Complexity Laboratory Director leads an experienced laboratory team that utilizes state-of-the-art technology to achieve positive outcomes.
Schedule a Free Consultation >
Island Reproductive Services provides a broad spectrum of infertility diagnosis and treatment services for both men and women. Conventional treatments, skilled surgical interventions and tubal reversals, as well as advanced reproductive technologies including IUI, IVF, ICSI, Blastocyst Transfer and Donor Programs are available. IRS offers specialized services for those seeking fertility preservation (egg and embryo cryopreservation), sex selection, PGD or patients experiencing Recurrent Pregnancy Loss.